Navigation Links
Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone
Date:8/1/2014

Chicago, Illinois (PRWEB) August 01, 2014

As AndroGel lawsuits and testosterone lawsuits continue to be filed across the country, Ronald E. Johnson, Jr. has been appointed as co-lead counsel to represent the men injured by AndroGel and other testosterone medications. Since the Fall of 2013, Ron and his firm, Schachter, Hendy & Johnson, P.S.C. have worked diligently to investigate and prosecute the claims of men who suffered heart attacks, strokes, pulmonary embolisms, and blood clots as a result of taking testosterone. As a result of these efforts, the medical community and public are being made aware of the true risks of taking testosterone.

In January 2014, the U.S. Food and Drug Administration (FDA) announced that it was investigating the safety of testosterone medications and their potential relationship to heart attacks and strokes (http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm). The FDA will hold a conference in September 2014 to address these issues.

The labeling for all testosterone medications was changed and broadened by the FDA on June 19, 2014 concerning the risks of blood clots (http://www.fda.gov/drugs/drugsafety/ucm401746.htm). Prior labeling only warned about blood clots in the legs as a result of polycythemia. The new labeling warns about blood clots in the legs and lungs generally and not as related to any specific condition other than testosterone use.

Lawsuits filed across the nation are being coordinated in a multi-district litigation (In Re: Testosterone Replacement Therapy Products Liability Litigation, 1:14-cv-01748) before Judge Matthew Kennelly in the Northern District of Illinois. As co-lead counsel for all plaintiffs in testosterone lawsuits, Ron will continue to fight for justice for the men and families whose lives have been devastated by the use of testosterone medications.

Read the full story at http://www.prweb.com/releases/testosteronelawsuit/androgelattorney/prweb12066446.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
2. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
3. The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
4. The US Drug Watchdog Now Urges Any Woman Who Used The Birth Control Pills Yaz Or Yasmin And Then Had A Heart Attack Or Stroke To Call The Johnson Law Group----ASAP
5. US Drug Watchdog Now Urges Women Who Used Yaz or Yasmin Birth Control Pills and Had a Heart Attack or Stroke to Call The Johnson Law Group immediately-Get Identified Now
6. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
7. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
8. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
9. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
10. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
11. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: